Research map: SMARCA4-Altered Malignancies: Cytologic Diagnostic Challenges and Clinicopathologic Correlates

Back to the article

Papers in this map

  1. Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing · Marcin B. Imielinski · 2012 · 1843 citations · Cited by this paper
  2. Association of genomic driver mutation, histologic subtype, and mTORC1 biomarker expression in mTOR pathway-altered renal tumors · 2026 · Related
  3. Frequent Mutations of Chromatin Remodeling Gene ARID1A in Ovarian Clear Cell Carcinoma · Siân Jones · 2010 · 1235 citations · Cited by this paper
  4. Single-section assessment of DNA mismatch repair using PMS2/MSH6 double immunohistochemistry · 2026 · Related
  5. Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic insights gained from human genomics · Cigall Kadoch · 2015 · 873 citations · Cited by this paper
  6. Metastatic pancreatic acinar cell carcinoma to the liver mimicking neuroendocrine tumor (NET) and pancreatic ductal adenocarcinoma (PDAC): A series of seven cases · 2026 · Related
  7. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4 · Pilar Ramos · 2014 · 396 citations · Cited by this paper
  8. Morphology spectrum and molecular landscape in eosinophilic solid and cystic renal cell carcinoma · 2026 · Related
  9. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas · François Le Loarer · 2015 · 382 citations · Cited by this paper
  10. Histologic spectrum of BRCA-associated pancreatic ductal adenocarcinoma: A descriptive morphologic study · 2026 · Related
  11. SMARCA4-Deficient Thoracic Sarcomatoid Tumors Represent Primarily Smoking-Related Undifferentiated Carcinomas Rather Than Primary Thoracic Sarcomas · Natasha Rekhtman · 2019 · 331 citations · Cited by this paper
  12. GPNMB immunohistochemistry distinguishes diagnostically challenging cases of lymphangioleiomyomatosis from other mesenchymal neoplasms presenting with cystic lung metastases · 2026 · Related
  13. The Genomic Landscape of SMARCA4 Alterations and Associations with Outcomes in Patients with Lung Cancer · Adam Jacob Schoenfeld · 2020 · 303 citations · Cited by this paper
  14. TSC gene-associated lesions of the lung · 2026 · Related
  15. SMARCA4-deficient Thoracic Sarcomas · Raul Ezequiel Perret · 2018 · 201 citations · Cited by this paper
  16. Mixed phenotype acute leukemia: Lineage assignment, immunophenotypic classification and genetic insights · 2026 · Related
  17. SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer · Yibo Xue · 2019 · 197 citations · Cited by this paper
  18. Molecular Subtypes and Genetic Diagnostics in B-cell Acute Lymphoblastic Leukemia · 2026 · Related
  19. Functional characterization of SMARCA4 variants identified by targeted exome-sequencing of 131,668 cancer patients · Tharu M. Fernando · 2020 · 161 citations · Cited by this paper
  20. Clinicopathologic and molecular characteristics of acral melanomas harboring RARA fusions · 2026 · Related
  21. SMARCA4 and Other SWItch/Sucrose NonFermentable Family Genomic Alterations in NSCLC: Clinicopathologic Characteristics and Outcomes to Immune Checkpoint Inhibition · Joao V. Alessi · 2021 · 160 citations · Cited by this paper
  22. Successful treatment with nivolumab for SMARCA4‐deficient non‐small cell lung carcinoma with a high tumor mutation burden: A case report · Tomoyuki Naito · 2019 · 101 citations · Cited by this paper
  23. Imaging features of SMARCA4-deficient thoracic sarcomas: a multi-centric study of 21 patients · Amandine Crombé · 2019 · 69 citations · Cited by this paper
  24. Perspectives and Issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients · Subasri Armon · 2021 · 55 citations · Cited by this paper
  25. Implementing a comprehensive translational oncology platform: from molecular testing to actionability · Zahi Ibrahim Mitri · 2018 · 46 citations · Cited by this paper
  26. Cytology of SMARCA4-Deficient Thoracic Neoplasms: Comparative Analysis of SMARCA4-Deficient Non-Small Cell Lung Carcinomas and SMARCA4-Deficient Thoracic Sarcomas · Aruna Nambirajan · 2020 · 46 citations · Cited by this paper
  27. Cytomorphologic features of SMARCA4 ‐deficient non–small cell lung carcinoma and correlation with immunohistochemical and molecular features · Tong Sun · 2022 · 19 citations · Cited by this paper
  28. NUT carcinoma and thoracic SMARCA4 ‐deficient undifferentiated tumour: facts and controversies · Akihiko Yoshida · 2023 · 18 citations · Cited by this paper
  29. SMARCA4 deficiency and mutations are frequent in large cell lung carcinoma and are prognostically significant · Alvin H.K. Cheung · 2024 · 14 citations · Cited by this paper
  30. Cytomorphologic and immunophenotypical analysis of SMARCA4 (BRG1)-deficient non-small cell lung carcinoma · Oluwaseun Basit Ogunbona · 2022 · 10 citations · Cited by this paper
  31. Fine‐needle aspiration and effusion cytology of thoracic SMARCA4–deficient undifferentiated tumor and SMARCA4‐deficient non–small cell lung carcinoma: A multi‐institutional experience with 27 patients · Nicole Zalles · 2024 · 3 citations · Cited by this paper
  32. Prognostic Implications of SMARCA4 , ARID1A , and Other BAF Mutations in Non‐Small Cell Lung Cancer · Alexis Khalil · 2025 · 3 citations · Cited by this paper
  33. Detection of targetable genetic alterations in SMARCA4-deficient neoplasms of the lung – further evidence of a relationship between SMARCA4-deficient undifferentiated tumor and non-small cell carcinoma · Danielle D'Ambrosio · 2025 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)